Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¼¼Æ÷°Ë»ç·Î À¯µÎ°©»ó»ù¾ÏÁ¾ÀÌ ÀǽɵǴ °©»ó»ù °áÀýÀÇ Galectin-3 ¹ßÇö°ú BRAF µ¹¿¬º¯ÀÌ ºÐ¼® Galectin-3 Expression and BRAF Mutation in Cases of Cytologically Suspicious Papillary Thyroid Carcinoma

´ëÇѺ´¸®ÇÐȸÁö 2010³â 44±Ç 2È£ p.191 ~ 198
±èµµ°æ, ±èÇöÁö, °ûÁø¿µ, ±è¹ÎÁÖ, Á¤ÇüÀç, ±¸ÀÚ½Â, ÀÓ¹üÁø, Á¤Âù±Ç, È«¼ø¿ø,
¼Ò¼Ó »ó¼¼Á¤º¸
±èµµ°æ ( Kim Do-Kyung ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

±èÇöÁö ( Kim Hyun-Gi ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
°ûÁø¿µ ( Kwak Jin-Young ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¿µ»óÀÇÇб³½Ç
±è¹ÎÁÖ ( Kim Min-Ju ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
Á¤ÇüÀç ( Jung Hyung-Jae ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
±¸Àڽ ( Koo Ja-Seung ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
ÀÓ¹üÁø ( Lim Beom-Jin ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
Á¤Âù±Ç ( Jung Chan-Kwon ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ï¼º¸ðº´¿ø º´¸®°ú
È«¼ø¿ø ( Hong Soon-Won ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

Abstract


Background: Fine needle aspiration, which is known as the most accurate and cost-effective method for diagnosis of thyroid nodule, still may result in indeterminate cases that are pauci-cellular and show minor nuclear atypia, but most cases are associated with suspicion of papillary thyroid carcinoma (PTC). A B-type Raf kinase (BRAF) mutation was found in about half of PTCs and galectin-3 was expressed by malignant tumors, helping us to differentiate malignancies from benign lesions.

Methods: Cases studied included histologically 44 confirmed PTC cases and 18 benign cases previously diagnosed as suspicious of PTC using cytologic examination. Cases were analyzed for galectin-3 expression by immunohistochemical staining and BRAF mutation by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) with a new restriction enzyme.

Results: All 44 cases of PTC and 8 of 18 benign controls expressed galectin-3. BRAF mutations were found in only 9 of the 44 PTC cases. Assessment of galectin-3 expression demonstrated high sensitivity but low specificity. Evaluation of BRAF mutation revealed high specificity and low sensitivity.

Conclusions: This study suggests that the combined application of these two methods for PTC of suspicious cytology is complementary.

Å°¿öµå

Suspicious cytology;Biopsy;fine needle;BRAF mutation;Galectin-3

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS